Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine-Reference-Cited by-同舟云学术

Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine

Published:2012-06 Issue: Volume:52 Page:251-262
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Samadi Abdelouahid,de los Ríos Cristóbal,Bolea Irene,Chioua Mourad,Iriepa Isabel,Moraleda Ignacio,Bartolini Manuela,Andrisano Vincenza,Gálvez Enrique,Valderas Carolina,Unzeta Mercedes,Marco-Contelles José

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference58 articles.

1. A Century of Alzheimer's Disease

2. Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

3. Oxidative stress in Alzheimer disease

4. Treatment of Alzheimer's disease; current status and new perspectives

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hippocampal acetylcholinesterase activation induced by streptozotocin in mice is protected by an organotellurium compound without evidence of toxicity;Anais da Academia Brasileira de Ciências;2024

2. Synthesis and bioactivity of 1-substituted tetrahydroisoquinolines derived from phenolic aldehydes;Organic Communications;2023-12-24

3. Synthesis of Novel Benzo[b][1,6]naphthyridine Derivatives and Investigation of Their Potential as Scaffolds of MAO Inhibitors;Molecules;2023-02-09

4. N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases;Molecules;2022-11-01

5. Multitargeting nature of muscarinic orthosteric agonists and antagonists;Frontiers in Physiology;2022-09-06